FDA Inspection
Padagis US LLCPadagis US LLC – FDA Inspection, Apr 8, 2026
Record Details
This FDA Inspection record concerns Padagis US LLC, with an inspection on April 8, 2026, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · 373ca705-cb64-4283-aa0e-f072b01b369b
Inspection Facts
- Inspection number
- 1304064
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 111.70(e)Specifications - finished dietary supplement
- 21 CFR 114.83Scheduled process establishment
- 21 CFR 117.130(a)(1)Hazard analysis - Identification of hazard
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.166(a)(2)Stability sample storage conditions described
- 21 CFR 211.56(b)Written sanitation procedures not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Padagis US LLC
11| Date | Classification | Office | Project area |
|---|---|---|---|
| September 6, 2024 | VAI | Minneapolis District Office | Drug Quality Assurance |
| January 31, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 5, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 18, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 23, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Padagis US LLC
- FDA Inspection 1248645 - 2024-09-06
- FDA Inspection 1228870 - 2024-01-31
- FDA Inspection 1207462 - 2023-05-05
- FDA Inspection 1162776 - 2022-02-18
- FDA Inspection 1108752 - 2019-10-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.